Metaxalone-d3 is a deuterium labeled Metaxalone, an FDA-approved muscle relaxant. It primarily acts on the central nervous system to achieve muscle relaxation by inhibiting polysynaptic reflex arcs. This compound also inhibits MAO-A, demonstrating anti-inflammatory and antioxidant effects. It inhibits IL-1β-induced inflammatory phenotype, modulates NF-κB and other related signaling pathways, and decreases MAO-A expression and activity in IL-1β-treated microglia.
- Deuterium labeled compound
- FDA-approved muscle relaxant
- Inhibits polysynaptic reflex arcs
- Inhibits MAO-A
- Provides anti-inflammatory and antioxidant effects
- Modulates NF-κB and related signaling pathways
- Decreases MAO-A expression and activity in IL-1β-treated microglia
- Used as a tracer for quantitation in drug development